A novel embryological theory of autism causation involving endogenous biochemicals capable of initiating cellular gene transcription: A possible link between twelve autism risk factors and the autism 'epidemic'

Medical Hypotheses

Volumn 76, Issue 5, 2011, Pages 653-660

  King, Chiara R ^a  

^a MHL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ALCOHOL; ALPHA FETOPROTEIN; ESTRADIOL; FOLIC ACID; INTERLEUKIN 6; RETINOIC ACID; THALIDOMIDE; VALPROIC ACID;

ACUTE PHASE RESPONSE; ALLERGIC REACTION; ARTICLE; ASPERGER SYNDROME; AUTISM; AUTOIMMUNE DISEASE; CAUSAL ATTRIBUTION; CONGENITAL MALFORMATION; CYTOMEGALOVIRUS INFECTION; DEPRESSION; EPIDEMIC; EPIGENETICS; GASTROINTESTINAL DISEASE; GENE EXPRESSION REGULATION; HERPES SIMPLEX; HUMAN; HYPOTHYROIDISM; MENTAL DEFICIENCY; NEURAL TUBE DEFECT; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; PRENATAL EXPOSURE; PROTEIN FUNCTION; PROTEIN SYNTHESIS REGULATION; RISK FACTOR; RUBELLA; SCHIZOPHRENIA; SEX RATIO; STRESS; SYMPTOMATOLOGY; TOXOPLASMOSIS; TRANSCRIPTION INITIATION; WHEAT ALLERGY;

ALPHA-FETOPROTEINS; ANIMALS; ASPERGER SYNDROME; AUTISTIC DISORDER; CELL PROLIFERATION; EPIGENESIS, GENETIC; ESTRADIOL; GASTROINTESTINAL DISEASES; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MENTAL RETARDATION; RATS; REGRESSION ANALYSIS; RISK; RISK FACTORS; TRANSCRIPTION, GENETIC; TREATMENT OUTCOME; TRETINOIN;

CYTOMEGALOVIRUS; RUBELLA; TRITICUM AESTIVUM;

EID: 79954428438     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.01.024     Document Type: Article

References (100)

1. American Psychiatric Association. Pervasive developmental disorders. In: Diagnostic and statistical manual of mental disorders. 4th ed. Text revision (DSM-IV-TR). Washington, DC: American Psychiatric Association; 2000. p. 69-70.
2. Centers for Disease Control and Prevention (CDC). Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, 2006. Surveillance Summaries, December 18, 2009. MMWR Morb Mortal Wkly Rep 2009;58(NoSS-10).
3. Kanner L. Autistic disturbances of affective contact. Nervous Child 1943, 2:217-250.
4. Strömland K., Nordin V., Miller M., Akerström B., Gillberg C. Autism in thalidomide embryopathy: a population study. Dev Med Child Neurol 1994, 36(4):351-356.
5. Rodier P.M., Ingram J.L., Tisdale B., Croog V.J. Linking etiologies in humans and animal models: studies of autism. Reprod Toxicol 1997, 11(2-3):417-422.
6. Carpenter E.M., Goddard J.M., Chisaka O., Manley N.R., Capecchi M.R. Loss of Hox-A1 (Hox-1.6) function results in the reorganization of the murine hindbrain. Development 1993, 118(4):1063-1075.
7. Mark M., Lufkin T., Vonesch J.L., et al. Two rhombomeres are altered in Hoxa-1 mutant mice. Development 1993, 119(2):319-338.
8. Williams G., King J., Cunningham M., Stephan M., Kerr B., Hersh J.H. Fetal valproate syndrome and autism: additional evidence of an association. Dev Med Child Neurol 2001, 43(3):202-206.
9. Arndt T.L., Stodgell C.J., Rodier P.M. The teratology of autism. Int J Dev Neurosci 2005, 23(2-3):189-199.
10. Ross S.A., McCaffery P.J., Drager U.C., de Luca L.M. Retinoids in embryonal development. Physiol Rev 2000, 80(3):1021-1054.
11. Morriss-Kay G.M., Murphy P., Hill R.E., Davidson D.R. Effects of retinoic acid excess on expression of Hox-2.9 and Krox-20 and on morphological segmentation in the hindbrain of mouse embryos. EMBO J 1991, 10(10):2985-2995.
12. Holder N., Hill J. Retinoic acid modifies development of the midbrain-hindbrain border and affects cranial ganglion formation in zebrafish embryos. Development 1991, 113(4):1159-1170.
13. Papalopulu N., Clarke J.D., Bradley L., Wilkinson D., Krumlauf R., Holder N. Retinoic acid causes abnormal development and segmental patterning of the anterior hindbrain in Xenopus embryos. Development 1991, 113(4):1145-1158.
14. Mizejewski G.J. Biological roles of alpha-fetoprotein during pregnancy and perinatal development. Exp Biol Med 2004, 229(6):439-463.
15. Hsu C., Chen C.N., Chen L.T., et al. Low-dose thalidomide treatment for advanced hepatocellular carcinoma [Abstract]. Oncology 2003, 65(3):242-249.
16. Bauman M.L., Kemper T.L. Neuroanatomic observations of the brain in autism: a review and future directions. Int J Dev Neurosci 2005, 23(2-3):183-187.
17. Zhang J., Smith D., Yamamoto M., Ma L., McCaffery P. The meninges is a source of retinoic acid for the late-developing hindbrain. J Neurosci 2003, 23(20):7610-7620.
18. Coudé F.X., Grimber G., Pelet A., Benoit Y. Action of the antiepileptic drug, valproic acid, on fatty acid oxidation in isolated rat hepatocytes. Biochem Biophys Res Commun 1983, 115(2):730-736.
19. Turnbull D.M., Dick D.J., Wilson L., Sherratt H.S., Alberti K.G. Valproate causes metabolic disturbance in normal man. J Neurol Neurosurg Psychiatry 1986, 49(4):405-410.
20. Bakker J., De Mees C., Douhard Q., et al. Alpha-fetoprotein protects the developing female mouse brain from masculinization and defeminization by estrogens. Nat Neurosci 2006, 9(2):220-226.
21. Weisz J., Ward I.L. Plasma testosterone and progesterone titers of pregnant rats, their male and female fetuses, and neonatal offspring [Abstract]. Endocrinology 1980, 106(1):306-316.
22. Montano M.M., Welshons W.V., vom Saal F.S. Free estradiol in serum and brain uptake of estradiol during fetal and neonatal sexual differentiation in female rats. Biol Reprod 1995, 53(5):1198-1207.
23. McEwen B.S. Estrogen actions throughout the brain. Recent Prog Horm Res 2002, 57:357-384.
24. Schneider S., Roman A., Basta-Kaim A., et al. Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid. Psychoneuroendocrinology 2008, 33(6):728-740.
25. McEwen B.S. The molecular and neuroanatomical basis for estrogen effects in the central nervous system. J Clin Endocr Metab 1999, 84(6):1790-1797.
26. McEwen B.S., Alves S.H. Estrogen actions in the central nervous system. Endocr Rev 1999, 20(3):279-307.
27. Muris P., Steerneman P., Merckelbach H., Holdrinet I., Meesters C. Comorbid anxiety symptoms in children with pervasive developmental disorders [Abstract]. J Anxiety Disord 1998, 12(4):387-393.
28. Dowell L.R., Mahone E.M., Mostofsky S.H. Associations of postural knowledge and basic motor skill with dyspraxia in autism: implication for abnormalities in distributed connectivity and motor learning. Neuropsychology 2009, 23(5):563-570.
29. Deykin E.Y., MacMahon B. The incidence of seizures among children with autistic symptoms [Abstract]. Am J Psychiatry 1979, 136(10):1310-1312.
30. Corbett B.A., Constantine L.J. Autism and attention deficit disorder: assessing attention and response control with the integrated visual and auditory continuous performance test. Child Neuropsychology 2006, 12(4-5):335-348.
31. Militerni R., Bravaccio C., Falco C., Puglisi-Allegra S., Pascuci T., Fico C. Pain reactivity in children with autistic disorder [Abstract]. J Headache Pain 2000, 1(1):53-56.
32. Cook E.H., Leventhal B.L. The serotonin system in autism. Curr Opin Pediatr 1996, 8(4):348-354.
33. Bennetto L., Pennington B.F., Rogers S.J. Intact and impaired memory functions in autism. Child Dev 1996, 67(4):1816-1835.
34. Bertone A., Mottron L., Jelenic P., Faubert J. Enhanced and diminished visuo-spatial information processing in autism depends on stimulus complexity. Brain 2005, 128(Pt 10):2430-2441.
35. Grumbach M.M., Auchus R.J. Estrogen: consequences and implications of human mutations in synthesis and action. J Clin Endocrinol Metab 1999, 84(12):4677-4694.
36. Bennett J.A., Zhu S., Pagano-Mirarchi A., Kellom T.A., Jacobson H.I. Alpha-fetoprotein derived from a human hepatoma prevents growth of estrogen-dependent human breast cancer xenografts. Clin Cancer Res 1998, 4(11):2877-2884.
37. Richardson B.E., Hulka B.S., Peck J.L., et al. Levels of maternal serum alpha-fetoprotein (AFP) in pregnant women and subsequent breast cancer risk. Am J Epidemiol 1998, 148(8):719-727.
38. Melbye M., Wohlfahrt J., Lei U., et al. Alpha-fetoprotein levels in maternal serum during pregnancy and maternal breast cancer incidence. J Natl Cancer Inst 2000, 92(12):1001-1005.
39. Shiina S., Tagawa K., Niwa Y., et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients. AJR Am J Roentgenol 1993, 160(5):1023-1028.
40. Halmesmäki E., Autti I., Granström M.L., Heikinheimo M., Raivio K.O., Ylikorkala O. Prediction of fetal alcohol syndrome by maternal alpha-fetoprotein, human placental lactogen and pregnancy specific beta 1-glycoprotein [Abstract]. Alcohol Alcohol Suppl 1987, 1:473-476.
41. Nanson J.L. Autism in fetal alcohol syndrome: a report of six cases [Abstract]. Alcohol Clin Exp Res 1992, 16(3):558-565.
42. Isom H.C., Liao W.S., Taylor J.M., Willwerth G.E., Eadline T.S. Rapid and selective shutoff of plasma protein production in herpes simplex virus type 2-infected hepatoma cells [Abstract]. Virology 1983, 126(2):548-562.
43. Brown Z.A., Selke S., Zeh J., et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997, 337(8):509-515.
44. Chess S. Autism in children with congenital rubella. J Autism Child Schizophr 1971, 1(1):33-47.
45. Stubbs E.G., Ash E., Williams C.P. Autism and congenital cytomegalovirus [Abstract]. J Autism Dev Disord 1984, 14(2):183-189.
46. Heinrich P.C., Castell J.V., Andus T. Interleukin-6 and the acute phase response. Biochem J 1990, 265(3):621-636.
47. Iwasa F., Galbraith R.A., Sassa S. Effects of dimethyl sulphoxide on the synthesis of plasma proteins in the human hepatoma HepG2. Induction of an acute-phase-like reaction. Biochem J 1988, 253(3):927-930.
48. Mackiewicz A., Schultz D., Mathison J., Ganapathi M., Kushner I. Effect of cytokines on glycosylation of acute phase proteins in human hepatoma cell lines. Clin Exp Immunol 1989, 75(1):70-75.
49. Frommberger U.H., Bauer J., Haselbauer P., Fräulin A., Riemann D., Berger M. Interleukin-6 (IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission [Abstract]. Eur Arch Psychiatry Clin Neurosci 1997, 247(4):228-233.
50. Maes M., Meltzer H.Y., Bosmans E. Psychoimmune investigation in obsessive-compulsive disorder: assays of plasma transferrin, IL-2 and IL-6 receptor, and IL-1 beta and IL-6 concentrations [Abstract]. Neuropsychobiology 1994, 30(2-3):57-60.
51. Daniels J.L., Forssen U., Hultman C.M., et al. Parental psychiatric disorders associated with autism spectrum disorders in the offspring. Pediatrics 2008, 121(5):e1357-e1362.
52. Maes M., Lin A., Delmeire L., et al. Elevated serum Interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events. Biol Psychiatry 1999, 45(7):833-839.
53. Beversdorf D.Q., Manning S.E., Hillier A., et al. Timing of prenatal stressors and autism. J Autism Dev Disord 2005, 35(4):471-478.
54. Ishihara K., Hirano T. IL-6 in autoimmune disease and chronic inflammatory proliferative disease [Abstract]. Cytokine Growth Factor Rev 2002, 13(4-5):357-368.
55. Sweeten T.L., Bowyer S.L., Posey D.J., Halberstadt G.M., McDougle C.J. Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. Pediatrics 2003, 112(5):e420.
56. Delneste Y., Lassalle P., Jeannin P., Joseph M., Tonnel A.B., Gosset P. Histamine induces IL-6 production by human endothelial cells. Clin Exp Immunol 1994, 98(2):344-349.
57. Croen L.A., Grether J.K., Yoshida C.K., Odouli R., Van de Water J. Maternal autoimmune diseases, asthma and allergies, and autism spectrum disorders: a case-control study. Arch Pediatr Adolesc Med 2005, 159(2):151-157.
58. Gillberg I.C., Gillberg C., Kopp S. Hypothyroidism and autism spectrum disorders [Abstract]. J Child Psychol Psychiatry 1992, 33(3):531-542.
59. Mittra I., Hayward J.L. Hypothalamic-pituitary-thyroid axis in breast cancer [Abstract]. Lancet 1974, 303(7863):885-889.
60. Eskin B.A. Iodine and mammary cancer. Adv Exp Med Biol 1977, 91:293-304.
61. Links P.S., Stockwell M., Abichandani F., Simeon J. Minor physical anomalies in childhood autism. Part I. Their relationship to pre- and perinatal complications [Abstract]. J Autism Dev Disord 1980, 10(3):273-285.
62. Konstantareas M.M., Homatidis S. Brief report: ear infections in autistic and normal children [Abstract]. J Autism Dev Disord 1987, 17(4):585-594.
63. Lord C., Schopler E. Differences in sex ratios in autism as a function of measured intelligence. J Autism Dev Disord 1985, 15(2):185-193.
64. Miles J.H., Hillman R.E. Value of a clinical morphology examination in autism. Am J Med Genet 2000, 91(4):245-253.
65. Gillberg C. Asperger syndrome in 23 Swedish children [Abstract]. Dev Med Child Neurol 1989, 31(4):520-531.
66. Ingudomnukul E., Baron-Cohen S., Wheelwright S., Knickmeyer R. Elevated rates of testosterone-related disorders in women with autism spectrum conditions. Horm Behav 2007, 51(5):597-604.
67. Geier D.A., Geier M.R. A clinical and laboratory evaluation of methionine cycle-transsulfuration and androgen pathway markers in children with autistic disorders. Horm Res 2006, 66(4):182-188.
68. Lutchmaya S., Baron-Cohen S., Raggatt P., Knickmeyer R., Manning J.T. 2nd to 4th Digit ratios, fetal testosterone and estradiol. Early Hum Dev 2004, 77(1-2):23-28.
69. Lutchmaya S., Baron-Cohen S., Raggatt P. Foetal testosterone and eye contact in 12-month-old human infants. Infant Behav Dev 2002, 25(3):327-335.
70. Knickmeyer R., Baron-Cohen S., Raggatt P., Taylor K. Foetal testosterone, social relationships, and restricted interests in children. J Child Psychol Psychiatry 2005, 46(2):198-210.
71. Harris J.A., Vernon P.A., Boomsma D.I. The heritability of testosterone: a study of Dutch adolescent twins and their parents. Behav Genet 1998, 28(3):165-171.
72. Mangelsdorf D.J., Thummel C., Beato M., et al. The nuclear receptor superfamily: the second decade. Cell 1995, 83(6):835-839.
73. Schneider T., Przewlocki R. Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology 2005, 30(1):80-89.
74. Hertz R. The quantitative relationship between stilbestrol response and dietary " folic acid" in the chick [Abstract]. Endocrinology 1945, 37(1):1-6.
75. Scheindlin S. Vicissitudes of a vitamin. MDD 2001, 4(8):61-63. 66.
76. Smithells R.W., Sheppard S., Schorah C.J., et al. Possible prevention of neural-tube defects by periconceptional vitamin supplementation [Abstract]. Lancet 1980, 1(8164):339-340.
77. Laurence K.M., James N., Miller M.H., Tennant G.B., Campbell H. Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. Br Med J 1981, 282(6275):1509-1511.
78. Czeizel A.E., Dudás I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992, 327(26):1832-1835.
79. Centers for Disease Control and Prevention (CDC). Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Morb Mortal Wkly Rep 1992;41(RR-14):1-7.
80. Food and Drug Administration (FDA). Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Federal Register 1996;61:8781-97.
81. California Department of Developmental Services. Changes in the population of persons with autism and pervasive developmental disorders in California's developmental services system: 1987 through 1998: a report to the Legislature. Sacramento: California Health and Human Services Agency, Department of Developmental Services 1999.
82. Byrd RS, Sage AC, Keyzer J, et al. Report to the Legislature on the principal findings from the epidemiology of autism in California: a comprehensive pilot study. Davis (CA): Mind Institute 2002 Oct 17.
83. Wald N.J., Law M.R., Morris J.K., Wald D.S. Quantifying the effect of folic acid. Lancet 2001, 358(9298):2069-2073.
84. van der Put N.M., Frosst P., Steegers-Theunissen R.P., et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida [Abstract]. Lancet 1995, 346(8982):1070-1071.
85. Relton C.L., Wilding C.S., Jonas P.A., Lynch S.A., Tawn E.J., Burn J. Genetic susceptibility to neural tube defect pregnancy varies with offspring phenotype. Clin Genet 2003, 64(5):424-428.
86. Afman L.A., van der Put N.M., Thomas C.M., Trijbels J.M., Blom H.J. Reduced vitamin B12 binding by transcobalamin II increases the risk of neural tube defects. QJM 2001, 94(3):159-166.
87. Selhub J. Homocysteine metabolism. Annu Rev Nutr 1999, 19:217-246.
88. Boris M., Goldblatt A., Galanko J., James S.J. Association of MTHFR gene variants with autism. J Am Physicians Surgeons 2004, 9(4):106-108.
89. James S.J., Melnyk S., Jernigan S., et al. Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am J Med Genet B Neuropsychiatr Genet 2006, 141B(8):947-956.
90. Rogers E.J. Has enhanced folate status during pregnancy altered natural selection and possibly Autism prevalence? A closer look at a possible link. Med Hypotheses 2008, 71(3):406-410.
91. Ulrey CL, Liu L, Andrews LG, Tollefsbol TO. The impact of metabolism on DNA methylation. Hum Mol Genet 2005;14 Spec No 1:R139-47.
92. Grattan-Smith P.J., Wilcken B., Procopis P.G., Wise G.A. The neurological syndrome of infantile cobalamin deficiency: developmental regression and involuntary movements [Abstract]. Mov Disord 1997, 12(1):39-46.
93. Ramaekers V.T., Hausler M., Opladen T., Heimann G., Blau N. Psychomotor retardation, spastic paraplegia, cerebellar ataxia and dyskinesia associated with low 5-methyltetrahydrofolate in cerebrospinal fluid: a novel neurometabolic condition responding to folinic acid substitution. Neuropediatrics 2002, 33(6):301-308.
94. Hollingsworth J.W., Maruoka S., Boon K., et al. In utero supplementation with methyl donors enhances allergic airway disease in mice. J Clin Invest 2008, 118(10):3462-3469.
95. Håberg S.E., London S.J., Stigum H., Nafstad P., Nystad W. Folic acid supplements in pregnancy and early childhood respiratory health. Arch Dis Child 2009, 94(3):180-184.
96. Whitrow M.J., Moore V.M., Rumbold A.R., Davies M.J. Effect of supplemental folic acid in pregnancy on childhood asthma: a prospective birth cohort study. Am J Epidemiol 2009, 170(12):1486-1493.
97. Centers for Disease Control and Prevention (CDC). Asthma prevalence and control characteristics by race/ethnicity - United States, 2002. MMWR Morb Mortal Wkly Rep 2004;53:145-8.
98. Branum A.M., Lukacs S.L. Food allergy among US children: trends in prevalence and hospitalizations. NCHS Data Brief 2008, 10:1-8.
99. Issa J.J., Ahuja N., Toyota M., Bronner M.P., Brentnall T.A. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res 2001, 61(9):3573-3577.
100. Roe D.A. Lucy Wills (1888-1964). A biographical sketch. J Nutr 1978, 108(9):1379-1383.